FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer - Breyer, Johannes; Erben, Philipp; Rinaldetti, Sébastien; Worst, Thomas (BJU international, 2019)
First published: 18 August 2018